levofloxacin has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalifa, MO; Mansour, MA | 1 |
| Ebisutani, C; Inoue, H; Kinoshita, Y; Nishi, K; Sato, S; Yoshie, T | 1 |
| Baltch, AL; Bopp, LH; Carlyn, CJ; Carpenter-Knaggs, A; Hibbs, JR; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
2 trial(s) available for levofloxacin and Liver Neoplasms
| Article | Year |
|---|---|
Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Catheterization, Peripheral; Ceftriaxone; Chemoembolization, Therapeutic; Ciprofloxacin; Drug Administration Routes; Drug Monitoring; Egypt; Female; Humans; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome | 2018 |
Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: an open randomized prospective study of oral versus intravenous administration.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Cefazolin; Chemoembolization, Therapeutic; Female; Humans; Inflammation Mediators; Infusions, Intra-Arterial; Infusions, Intravenous; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Ofloxacin; Postoperative Complications; Prospective Studies; Treatment Outcome | 2010 |
1 other study(ies) available for levofloxacin and Liver Neoplasms
| Article | Year |
|---|---|
Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.
Topics: Anti-Infective Agents; Carcinoma; Chlamydia Infections; Chlamydophila pneumoniae; Hepatocytes; Humans; Interleukin-6; Levofloxacin; Liver Neoplasms; Ofloxacin; Tumor Cells, Cultured | 2003 |